Title |
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial
|
---|---|
Published in |
BMC Complementary Medicine and Therapies, May 2014
|
DOI | 10.1186/1472-6882-14-159 |
Pubmed ID | |
Authors |
Yves Henrotin, Myriam Gharbi, Yvan Dierckxsens, Fabian Priem, Marc Marty, Laurence Seidel, Adelin Albert, Elisabeth Heuse, Valérie Bonnet, Caroline Castermans |
Abstract |
The management of osteoarthritis (OA) remains a challenge. There is a need not only for safe and efficient treatments but also for accurate and reliable biomarkers that would help diagnosis and monitoring both disease activity and treatment efficacy. Curcumin is basically a spice that is known for its anti-inflammatory properties. In vitro studies suggest that curcumin could be beneficial for cartilage in OA. The aim of this exploratory, non-controlled clinical trial was to evaluate the effects of bio-optimized curcumin in knee OA patients on the serum levels of specific biomarkers of OA and on the evaluation of pain. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
United Kingdom | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 2 | 1% |
United Kingdom | 1 | <1% |
Unknown | 155 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 30 | 19% |
Researcher | 20 | 13% |
Student > Master | 17 | 11% |
Student > Ph. D. Student | 11 | 7% |
Student > Postgraduate | 10 | 6% |
Other | 21 | 13% |
Unknown | 49 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 43 | 27% |
Biochemistry, Genetics and Molecular Biology | 15 | 9% |
Nursing and Health Professions | 14 | 9% |
Agricultural and Biological Sciences | 14 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
Other | 15 | 9% |
Unknown | 51 | 32% |